Day: September 22, 2018

  1. Home
  2. Archives: September 2018

Orphazyme closes a €14 million Series B Extension

Orphazyme closes a €14 million Series B Extension

Recent Posts

  • New ALS Association Partnership with ALS Investment Fund Targets $100 Million in New Funding for ALS Therapeutic Development
  • Amylyx Pharmaceuticals Announces AMX0035 Demonstrated Statistically Significant Treatment Benefit for People with ALS in the CENTAUR Trial
  • Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders
  • Search for cure against the lethal disease ALS boosted by new investor
  • Orphazyme closes a €14 million Series B Extension

ROBERT BROWN

Scientific Advisory Board